Indian Army Department Of Military Affairs Pharmaceutical Supplies Tender Chennai 2026 – WHO/GMP, OEM Authorisation, EMD ₹50,000
Bid Publish Date
09-Jul-2026, 9:10 am
Bid End Date
20-Jul-2026, 10:00 am
Value
₹4,00,000
Location
Progress
Quantity
6527
Category
AXITINIB 5 MG TAB
Bid Type
Two Packet Bid
Categories
9
Tender Overview
The Indian Army (Department Of Military Affairs) solicits supply of pharmaceutical and medical items for Commandant Military Hospital, Chennai with an estimated value of ₹400,000. The scope covers multiple drugs, injections, and related medical consumables listed in the BOQ, with EMD ₹50,000 required in physical form. The award may include quantity adjustments up to 25% during/after contract at contracted rates. The tender emphasizes compliance with OEM authorisations for MH Chennai and requires strict shelf-life and warranty adherence. This procurement targets vendors capable of meeting military-grade quality and cold-chain stipulations where applicable, and requires submission of essential technical documents upfront.
Technical Specifications & Requirements
- No explicit product performance specs are published in the tender text; the emphasis is on compliance documentation and supply capabilities.
- Mandatory documents include: Experience certificate, Past performance, Bidder turnover, OEM authorization (for MH Chennai), WHO/GMP certificate, Drug license, GST certificate, PAN, Aadhar, Cancel cheque, and Mandate form.
- Additional obligations: non-blacklisted certificate on ₹100 stamp paper, EMD submission before technical opening, and sample item requests during technical evaluation.
- Vendors must provide an undertaking that 30-60% shelf-life commitments are maintained and that replacements for expiring items are offered 4 months prior to expiry; a 5/6th shelf-life requirement is explicitly requested. All items must be supplied in full quantity if awarded.
Terms & Eligibility
- EMD: ₹50,000 via physical submission to Commandant Military Hospital, Chennai.
- Delivery/order flexibility: option to increase/decrease quantity up to 25%, with corresponding delivery extension rules.
- OEM prerequisites: OEM authorization specifically noted for MH Chennai; WHO/GMP certification required from the OEM.
- Financials: bidder must provide three years of ITR and balance sheet; 3-year turnover details accepted; 3-year net worth or turnover indicators not explicitly given but implied.
- Documentation: mandatory project experience, past performance records, drug licensing, and no-blacklist certificate; mandatory sample provisions during evaluation.
Key Specifications
-
- Product/service: Pharmaceutical drugs and medical consumables listed under procurement for Indian Army hospital in Chennai
-
- Quantities: Not disclosed per-item; total estimated value ₹400,000
-
- EMD: ₹50,000 (physical submission)
-
- Standards/certifications: WHO/GMP certificate for OEM, no explicit IS/ISO beyond GMP
-
- Documentation: OEM authorization for MH Chennai, Drug license, GST, PAN, audited financials, 3 years ITR
-
- shelf life: minimum 5/6th shelf life at delivery; replacement obligation 4 months before expiry
-
- Delivery/contract flexibility: option clause allowing ±25% quantity adjustment
Terms & Conditions
-
EMD of ₹50,000 to be physically submitted before technical opening
-
Quantity may be increased/decreased by up to 25% at contract rates
-
OEM authorization required specifically for MH Chennai
-
WHO/GMP certificate of the OEM is mandatory
-
5/6th shelf life at delivery and 4-month expiry replacement obligation
-
Full supply of quoted items; no partial cancellations after order placement
Important Clauses
Payment Terms
EMD ₹50,000 to be submitted physically; no digital substitutes mentioned
Delivery Schedule
Delivery timelines tied to original/delivered quantity; option to extend per formula with minimum 30 days
Penalties/Liquidated Damages
Not explicitly detailed; standard government procurement penalties implied via contract terms
Bidder Eligibility
-
Experience in supplying pharmaceutical items to government or military facilities
-
Valid drug license and GST registration
-
OEM authorization for MH Chennai and WHO/GMP certification
Additional Tender Data
Commercial Details
Tender Category
Goods
Bid To RA
No
Bid To RA Enabled
No
Item Category
AXITINIB 5 MG TAB , BICALUTAMIDE 50MG TAB , IMATINIB MESYLATE 100MG TAB , INJ DENOSUMAB SOLUTION 60 MG PER ML PROLLIA , NINTEDANIB 150 MG CAP , SORAFENIB 200 MG TAB , TEMOZOLOMIDE 250MG CAP , Tab Relugolix 120 mg , Inj Zoledronic ACID 4 MG , EXEMESTANE 25 MG TAB , TAMOXIFEN CITRATE 20 MG TAB , Inj Degarelix 80 mg , SOFOSBUVIR 400MG PLUS VELPATASVIR 100MG CAP , Inj Bortezumab 2 mg , Tab Nilotinib 200 mg , Tab Glutathiaone 250 mg , LEUPROLIDE ACETATE 11 POINT 25 MG INJ , Tab Azacitidine 200 mg , Tab Fingolimod 0 point 5 mg , Inj Triptorelin 22 point 5 mg , Inj Palonosetron 0 point 25 mg , Inj Paclitaxel 60 mg , Cap Netupitant 300 mg Plus Palonosetron 0 Point 5 mg , Inj Carboplatin 150 mg , Inj Pemetrexed 400 mg , Inj Paclitaxel 100 mg , Inj Darbepoetin alfa 200 mcg , Inj Romiplostim 250 mcg , Inj Octreotide 30 mg , FILGRASTIM 300 MCG INJ , Inj Fosnetupitant 235 mg Plus Palonosetron 0 Point 25 mg , inj Iron Isomaltoside 1000 mg , Inj Azithromycin 500 mg , Inj Immunomodulator 0 point 2 ml , Inj Adriamycin 80 mg , Inj Pegfilgrastim 6 mg , Urostomy Bag 45 mm , Urostomy Pouch Bag 45 mm , Urostomy Belt , Tab Pomalidimide 4 mg
Authority Records
BID & GeM Expert Consultancy
End-to-end support — bid preparation, GeM registration, document filing & compliance by industry experts.
Free consultation · 24h response
Documents 4
GeM-Bidding-9567274.pdf
Main Document
BOQ Document
BOQ
BOQ Document
BOQ
GEM General Terms and Conditions Document
GEM_GENERAL_TERMS_AND_CONDITIONS
Bill of Quantities (BOQ)
40 Items Sign in to view GEM price trends Sign in for GEM prices
AXITINIB 5 MG TAB
AXITINIB 5 MG TAB
BICALUTAMIDE 50MG TAB
BICALUTAMIDE 50MG TAB
IMATINIB MESYLATE 100MG TAB
IMATINIB MESYLATE 100MG TAB
INJ DENOSUMAB SOLUTION 60 MG PER ML PROLLIA
INJ DENOSUMAB SOLUTION 60 MG/ML (PROLLIA)
NINTEDANIB 150 MG CAP
NINTEDANIB 150 MG CAP
SORAFENIB 200 MG TAB
SORAFENIB 200 MG TAB
TEMOZOLOMIDE 250MG CAP
TEMOZOLOMIDE 250MG CAP
Tab Relugolix 120 mg
Tab Relugolix 120 mg
Inj Zoledronic ACID 4 MG
Inj Zoledronic ACID 4 MG
EXEMESTANE 25 MG TAB
EXEMESTANE 25 MG TAB
TAMOXIFEN CITRATE 20 MG TAB
TAMOXIFEN CITRATE 20 MG TAB
Inj Degarelix 80 mg
Inj Degarelix 80 mg
SOFOSBUVIR 400MG PLUS VELPATASVIR 100MG CAP
SOFOSBUVIR 400MG + VELPATASVIR 100MG CAP
Inj Bortezumab 2 mg
Inj Bortezumab 2 mg
Tab Nilotinib 200 mg
Tab Nilotinib 200 mg
Tab Glutathiaone 250 mg
Tab Glutathiaone 250 mg
LEUPROLIDE ACETATE 11 POINT 25 MG INJ
LEUPROLIDE ACETATE 11.25 MG INJ
Tab Azacitidine 200 mg
Tab Azacitidine 200 mg
Tab Fingolimod 0 point 5 mg
Tab Fingolimod 0.5 mg
Inj Triptorelin 22 point 5 mg
Inj Triptorelin 22.5 mg
Inj Palonosetron 0 point 25 mg
Inj Palonosetron 0.25 mg
Inj Paclitaxel 60 mg
Inj Paclitaxel 60 mg
Cap Netupitant 300 mg Plus Palonosetron 0 Point 5 mg
Cap Netupitant 300 mg+Palonosetron 0.5 mg
Inj Carboplatin 150 mg
Inj Carboplatin 150 mg
Inj Pemetrexed 400 mg
Inj Pemetrexed 400 mg
Inj Paclitaxel 100 mg
Inj Paclitaxel 100 mg
Inj Darbepoetin alfa 200 mcg
Inj Darbepoetin alfa 200 mcg
Inj Romiplostim 250 mcg
Inj Romiplostim 250 mcg
Inj Octreotide 30 mg
Inj Octreotide 30 mg
FILGRASTIM 300 MCG INJ
FILGRASTIM 300 MCG INJ
Inj Fosnetupitant 235 mg Plus Palonosetron 0 Point 25 mg
Inj Fosnetupitant 235 mg+Palonosetron 0.25 mg
inj Iron Isomaltoside 1000 mg
inj Iron Isomaltoside 1000 mg
Inj Azithromycin 500 mg
Inj Azithromycin 500 mg
Inj Immunomodulator 0 point 2 ml
Inj Immunomodulator 0.2 ml
Inj Adriamycin 80 mg
Inj Adriamycin 80 mg
Inj Pegfilgrastim 6 mg
Inj Pegfilgrastim 6 mg
Urostomy Bag 45 mm
Urostomy Bag 45 mm
Urostomy Pouch Bag 45 mm
Urostomy Pouch Bag 45 mm
Urostomy Belt
Urostomy Belt
Tab Pomalidimide 4 mg
Tab Pomalidimide 4 mg
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) | Price Trends |
|---|---|---|---|---|---|---|---|
| 1 | AXITINIB 5 MG TAB | AXITINIB 5 MG TAB | 270 | no | oicdglpcell | 30 | |
| 2 | BICALUTAMIDE 50MG TAB | BICALUTAMIDE 50MG TAB | 2,040 | no | oicdglpcell | 30 | |
| 3 | IMATINIB MESYLATE 100MG TAB | IMATINIB MESYLATE 100MG TAB | 450 | no | oicdglpcell | 30 | |
| 4 | INJ DENOSUMAB SOLUTION 60 MG PER ML PROLLIA | INJ DENOSUMAB SOLUTION 60 MG/ML (PROLLIA) | 28 | pfs | oicdglpcell | 30 | |
| 5 | NINTEDANIB 150 MG CAP | NINTEDANIB 150 MG CAP | 2,008 | no | oicdglpcell | 30 | |
| 6 | SORAFENIB 200 MG TAB | SORAFENIB 200 MG TAB | 450 | no | oicdglpcell | 30 | |
| 7 | TEMOZOLOMIDE 250MG CAP | TEMOZOLOMIDE 250MG CAP | 15 | no | oicdglpcell | 30 | |
| 8 | Tab Relugolix 120 mg | Tab Relugolix 120 mg | 540 | no | oicdglpcell | 30 | |
| 9 | Inj Zoledronic ACID 4 MG | Inj Zoledronic ACID 4 MG | 7 | no | oicdglpcell | 30 | |
| 10 | EXEMESTANE 25 MG TAB | EXEMESTANE 25 MG TAB | 90 | no | oicdglpcell | 30 | |
| 11 | TAMOXIFEN CITRATE 20 MG TAB | TAMOXIFEN CITRATE 20 MG TAB | 90 | no | oicdglpcell | 30 | |
| 12 | Inj Degarelix 80 mg | Inj Degarelix 80 mg | 3 | no | oicdglpcell | 30 | |
| 13 | SOFOSBUVIR 400MG PLUS VELPATASVIR 100MG CAP | SOFOSBUVIR 400MG + VELPATASVIR 100MG CAP | 60 | no | oicdglpcell | 30 | |
| 14 | Inj Bortezumab 2 mg | Inj Bortezumab 2 mg | 1 | no | oicdglpcell | 30 | |
| 15 | Tab Nilotinib 200 mg | Tab Nilotinib 200 mg | 90 | no | oicdglpcell | 30 | |
| 16 | Tab Glutathiaone 250 mg | Tab Glutathiaone 250 mg | 90 | no | oicdglpcell | 30 | |
| 17 | LEUPROLIDE ACETATE 11 POINT 25 MG INJ | LEUPROLIDE ACETATE 11.25 MG INJ | 4 | no | oicdglpcell | 30 | |
| 18 | Tab Azacitidine 200 mg | Tab Azacitidine 200 mg | 42 | no | oicdglpcell | 30 | |
| 19 | Tab Fingolimod 0 point 5 mg | Tab Fingolimod 0.5 mg | 90 | no | oicdglpcell | 30 | |
| 20 | Inj Triptorelin 22 point 5 mg | Inj Triptorelin 22.5 mg | 1 | no | oicdglpcell | 30 | |
| 21 | Inj Palonosetron 0 point 25 mg | Inj Palonosetron 0.25 mg | 1 | no | oicdglpcell | 30 | |
| 22 | Inj Paclitaxel 60 mg | Inj Paclitaxel 60 mg | 1 | no | oicdglpcell | 30 | |
| 23 | Cap Netupitant 300 mg Plus Palonosetron 0 Point 5 mg | Cap Netupitant 300 mg+Palonosetron 0.5 mg | 9 | no | oicdglpcell | 30 | |
| 24 | Inj Carboplatin 150 mg | Inj Carboplatin 150 mg | 3 | no | oicdglpcell | 30 | |
| 25 | Inj Pemetrexed 400 mg | Inj Pemetrexed 400 mg | 1 | no | oicdglpcell | 30 | |
| 26 | Inj Paclitaxel 100 mg | Inj Paclitaxel 100 mg | 1 | no | oicdglpcell | 30 | |
| 27 | Inj Darbepoetin alfa 200 mcg | Inj Darbepoetin alfa 200 mcg | 2 | no | oicdglpcell | 30 | |
| 28 | Inj Romiplostim 250 mcg | Inj Romiplostim 250 mcg | 4 | no | oicdglpcell | 30 | |
| 29 | Inj Octreotide 30 mg | Inj Octreotide 30 mg | 1 | no | oicdglpcell | 30 | |
| 30 | FILGRASTIM 300 MCG INJ | FILGRASTIM 300 MCG INJ | 3 | no | oicdglpcell | 30 | |
| 31 | Inj Fosnetupitant 235 mg Plus Palonosetron 0 Point 25 mg | Inj Fosnetupitant 235 mg+Palonosetron 0.25 mg | 1 | no | oicdglpcell | 30 | |
| 32 | inj Iron Isomaltoside 1000 mg | inj Iron Isomaltoside 1000 mg | 1 | no | oicdglpcell | 30 | |
| 33 | Inj Azithromycin 500 mg | Inj Azithromycin 500 mg | 1 | no | oicdglpcell | 30 | |
| 34 | Inj Immunomodulator 0 point 2 ml | Inj Immunomodulator 0.2 ml | 1 | no | oicdglpcell | 30 | |
| 35 | Inj Adriamycin 80 mg | Inj Adriamycin 80 mg | 1 | no | oicdglpcell | 30 | |
| 36 | Inj Pegfilgrastim 6 mg | Inj Pegfilgrastim 6 mg | 1 | no | oicdglpcell | 30 | |
| 37 | Urostomy Bag 45 mm | Urostomy Bag 45 mm | 30 | no | oicdglpcell | 30 | |
| 38 | Urostomy Pouch Bag 45 mm | Urostomy Pouch Bag 45 mm | 30 | no | oicdglpcell | 30 | |
| 39 | Urostomy Belt | Urostomy Belt | 3 | no | oicdglpcell | 30 | |
| 40 | Tab Pomalidimide 4 mg | Tab Pomalidimide 4 mg | 63 | no | oicdglpcell | 30 |
🤖 AI-Powered Bidder Prediction
Discover companies most likely to bid on this tender
Required Documents
GST certificate
PAN card
Experience certificates
Financial statements (3 years ITR and balance sheet)
EMD document (₹50,000) in physical form
OEM authorization (for MH Chennai)
WHO/GMP certificate of the OEM
Drug license
Non-conviction certificate
Non-blacklisted certificate on ₹100 stamp paper
Cancel cheque and bank mandate form
Aadhar card
Photographs or shop blueprint and proof of cold storage (where applicable)
Frequently Asked Questions
Key insights about TAMIL NADU tender market
How to bid for Indian Army medicine tender in Chennai 2026?
Bidders must submit mandatory documents including GST, PAN, 3 years ITR, balance sheet, drug license, OEM authorization for MH Chennai, and WHO/GMP certificate. EMD ₹50,000 is required physically before technical opening. Ensure full item quotation and adherence to shelf-life obligations; include required undertakings for 5/6th shelf life and 4-month expiry replacements.
What documents are required for the MH Chennai pharma tender 2026?
Required documents include GST certificate, PAN, drug license, WHO/GMP certificate, OEM authorization for MH Chennai, EMD ₹50,000 (physical), 3 years ITR and balance sheet, experience certificates, non-blacklisted certificate on ₹100 stamp, and bank mandate with cancelled cheque; also a non-disclosure and proof of cold storage may be requested.
What shelf-life commitments are expected for supplied medicines?
Vendors must guarantee a minimum 5/6th shelf life at the time of delivery and provide an undertaking that any items expiring within 4 months will be replaced at no extra cost; this is critical for military hospital stock management and uninterrupted patient care.
What is the EMD amount and how must it be submitted?
The EMD is ₹50,000 and must be submitted in physical form to the Commandant Military Hospital, Chennai, placed in a sealed envelope indicating BID details; online submissions are not acceptable for EMD per terms.
What is the scope of quantity adjustments in this tender?
The purchaser may alter the quantity by up to 25% of the bid quantity at contract. During extended delivery, the added time is calculated by the formula (Increased quantity ÷ Original quantity) × Original delivery period, with a minimum of 30 days.
Which certifications are mandatory for OEMs under this bid in Chennai?
OEMs must provide WHO/GMP certification and OEM authorization specifically for MH Chennai; this ensures pharmaceutical quality controls meet government hospital standards and that the supplier is recognized as an authorized vendor.
What are the key submission requirements for the technical bid?
Submit experience certificates, past performance, OEM authorization, turnover certificates, GST, PAN, Aadhar, bank details, and the physical EMD. Include a 5/6th shelf-life undertaking, 4-month expiry replacement commitment, sample items if requested, and no-blacklisted certification on ₹100 stamp paper.
When will samples be requested and evaluated for this procurement?
Samples may be requested at the time of technical evaluation; vendors should be prepared to supply sample items for quality/verifications to validate WHO/GMP compliance and drug licensing alignment with MH Chennai requirements.
Explore More Opportunities
Unlock Tender Documents
Sign up now to access all documents
Documents 4
GeM-Bidding-9567274.pdf
Main Document
BOQ Document
BOQ
BOQ Document
BOQ
GEM General Terms and Conditions Document
GEM_GENERAL_TERMS_AND_CONDITIONS